ArticleACS central science2026
Isomer-Resolved Mass Spectrometry Imaging Reveals Regional and Age-Dependent Glycolipid Metabolism in Rat Brain.
Article in ACS central science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A New Lens on Glycolipid Isomers in Spatial Neurobiology.ACS central science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Glycolipids are essential for myelin integrity, but their extensive isomeric complexity, where isomers like galactosylceramide (GalCer) and glucosylceramide (GlcCer) have unique functions, has hindered our ability to map their metabolism in the brain. Existing mass spectrometry methods fail to resolve this complexity. We fundamentally overcome this barrier with a powerful new isomer-resolved mass spectrometry imaging workflow. By coupling ion mobility and mass spectrometry imaging with targeted enzymatic pretreatment, our method provides direct visualization of distinct de novo metabolic pathways for GalCer and GlcCer in situ. When applied to rat brains across the lifespan (2, 6, and 12 months), this technology revealed a previously unrecognized age-related decline that selectively affected the GalCer pathway, while the isomeric GlcCer pathway remained comparatively stable. We confirmed these metabolic alterations colocalize with myelin-associated proteins specifically in oligodendrocyte-rich regions, providing a functional link to altered oligodendrocyte-related lipid metabolism. This integrated approach provides a new paradigm for dissecting isomer-specific glycolipid metabolism, offering insight into lipid alterations in brain aging and opening new avenues for biomarker discovery in neurodegeneration.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.